Journal of International Oncology ›› 2024, Vol. 51 ›› Issue (6): 321-325.doi: 10.3760/cma.j.cn371439-20240215-00055
• Original Articles • Previous Articles Next Articles
Liu Na(), Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou
Received:
2024-02-15
Revised:
2024-03-19
Online:
2024-06-08
Published:
2024-06-28
Contact:
Liu Na, Email: Supported by:
Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou. Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
"
一般临床资料 | 对照组(n=90) | 肺癌组(n=90) | t/χ2值 | P值 |
---|---|---|---|---|
年龄(岁) | 55.28±6.74 | 56.73±6.85 | 1.43 | 0.154 |
性别 | ||||
男 | 53(58.89) | 57(63.33) | 0.37 | 0.541 |
女 | 37(41.11) | 33(36.67) | ||
BMI(kg/m2) | 22.47±3.25 | 21.89±3.47 | 1.16 | 0.249 |
吸烟史 | ||||
无 | 62(68.89) | 57(63.33) | 0.62 | 0.431 |
有 | 28(31.11) | 33(36.67) | ||
饮酒史 | ||||
无 | 59(65.56) | 51(56.67) | 1.50 | 0.221 |
有 | 31(34.44) | 39(43.33) | ||
结节直径(mm) | 14.58±3.96 | 19.76±4.03 | 8.70 | <0.001 |
病理类型 | ||||
NSCLC | - | 74(82.22) | - | - |
SCLC | - | 16(17.78) |
[1] | Wéber A, Morgan E, Vignat J, et al. Lung cancer mortality in the wake of the changing smoking epidemic: a descriptive study of the global burden in 2020 and 2040[J]. BMJ Open, 2023, 13(5): e065303. DOI: 10.1136/bmjopen-2022-065303. |
[2] | Ning J, Ge T, Jiang ML, et al. Early diagnosis of lung cancer: which is the optimal choice?[J]. Aging (Albany NY), 2021, 13(4): 6214-6227. DOI: 10.18632/aging.202504. |
[3] |
Chen M, Copley SJ, Viola P, et al. Radiomics and artificial intelligence for precision medicine in lung cancer treatment[J]. Semin Cancer Biol, 2023, 93: 97-113. DOI: 10.1016/j.semcancer.2023.05.004.
pmid: 37211292 |
[4] |
Zhou LY, Wang W, Wang FF, et al. Plasma-derived exosomal miR-15a-5p as a promising diagnostic biomarker for early detection of endometrial carcinoma[J]. Mol Cancer, 2021, 20(1): 57. DOI: 10.1186/s12943-021-01352-4.
pmid: 33781255 |
[5] | Wang Z, Li TE, Chen M, et al. MiR-106b-5p contributes to the lung metastasis of breast cancer via targeting CNN1 and regulating Rho/ROCK1 pathway[J]. Aging (Albany NY), 2020, 12(2): 1867-1887. DOI: 10.18632/aging.102719. |
[6] |
Zhu YC, Zhang C, Jiang B, et al. MiR-760 targets HBEGF to control cartilage extracellular matrix degradation in osteoarthritis[J]. J Orthop Surg Res, 2023, 18(1): 186. DOI: 10.1186/s13018-023-03664-1.
pmid: 36894989 |
[7] | Yu WL, Wang L, Liu S, et al. Combination of serum ACSL4 levels and low-dose 256-slice spiral CT exhibits the potential in the early screening of lung cancer[J]. Medicine (Baltimore), 2023, 102(5): e32733. DOI: 10.1097/MD.0000000000032733. |
[8] |
Zheng YJ, Fang ZY, Xue Y, et al. Specific gut microbiome signature predicts the early-stage lung cancer[J]. Gut Microbes, 2020, 11(4): 1030-1042. DOI: 10.1080/19490976.2020.1737487.
pmid: 32240032 |
[9] | Wang YZ, Lv YB, Li GY, et al. Value of low-dose spiral CT combined with circulating miR-200b and miR-200c examinations for lung cancer screening in physical examination population[J]. Eur Rev Med Pharmacol Sci, 2021, 25(19): 6123-6130. DOI: 10.26355/eurrev_202110_26890. |
[10] |
Xu KH, Zhang CP, Du TT, et al. Progress of exosomes in the diagnosis and treatment of lung cancer[J]. Biomed Pharmacother, 2021, 134: 111111. DOI: 10.1016/j.biopha.2020.111111.
pmid: 33352449 |
[11] | Farré PL, Duca RB, Massillo C, et al. MiR-106b-5p: a master regulator of potential biomarkers for breast cancer aggressiveness and prognosis[J]. Int J Mol Sci, 2021, 22(20): 11135. DOI: 10.3390/ijms222011135. |
[12] | Shi Y, Zhang B, Zhu J, et al. MiR-106b-5p inhibits IRF1/IFN-β signaling to promote M2 macrophage polarization of glioblastoma[J]. Onco Targets Ther, 2020, 13: 7479-7492. DOI: 10.2147/OTT.S238975. |
[13] |
Yang F, Sun ZW, Wang DY, et al. MiR-106b-5p regulates eso-phageal squamous cell carcinoma progression by binding to HPGD[J]. BMC Cancer, 2022, 22(1): 308. DOI: 10.1186/s12885-022-09404-8.
pmid: 35317779 |
[14] | Yong WM, Deng SJ, Tan YF, et al. Circular RNA circSLC8A1 inhibits the proliferation and invasion of non-small cell lung cancer cells through targeting the miR-106b-5p /FOXJ3 axis[J]. Cell Cycle, 2021, 20(24): 2597-2606. DOI: 10.1080/15384101.2021.1995968. |
[15] | Yang YZ, Zhang YF, Yang L, et al. MiR‑760 mediates hypoxia-induced proliferation and apoptosis of human pulmonary artery smooth muscle cells via targeting TLR4[J]. Int J Mol Med, 2018, 42(5): 2437-2446. DOI: 10.3892/ijmm.2018.3862. |
[16] | Wang S, Yang Y, Cao YD, et al. Androgen downregulation of miR-760 promotes prostate cancer cell growth by regulating IL6[J]. Asian J Androl, 2021, 23(1): 85-90. DOI: 10.4103/aja.aja_20_20. |
[17] | Wu XD, Chen H, Liu N, et al. Curcumin suppresses lung cancer progression via circRUNX1 mediated miR-760/RAB3D axis[J]. Thorac Cancer, 2023, 14(5): 506-516. DOI: 10.1111/1759-7714.14773. |
[18] | Wang W, He B. MiR-760 inhibits the progression of non-small cell lung cancer through blocking ROS1/Ras/Raf/MEK/ERK pathway[J]. Biosci Rep, 2020, 30: BSR20182483. DOI: 10.1042/BSR 20182483. |
[19] | El-Aal AEA, Elshafei A, Ismail MY, et al. Identification of miR-106b-5p, miR-601, and miR-760 expression and their clinical values in non-small cell lung cancer (NSCLC) patients' serum[J]. Pathol Res Pract, 2023, 248: 154663. DOI: 10.1016/j.prp.2023.154663. |
[20] |
Zheng CQ, Wang HF, Liu QZ, et al. Application effect of low-dose spiral CT on pulmonary nodules and its diagnostic value for benign and malignant nodules[J]. Am J Transl Res, 2023, 15(1): 256-263.
pmid: 36777849 |
[1] | Yuan Jian, Huang Yanhua. Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer [J]. Journal of International Oncology, 2024, 51(6): 338-343. |
[2] | Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi. Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer [J]. Journal of International Oncology, 2024, 51(5): 286-291. |
[3] | Chen Qi, Xu Chenyang, Wang Yin, Lei Dapeng. Current application status of hyperspectral imaging in the diagnosis and treatment of head and neck tumor [J]. Journal of International Oncology, 2024, 51(5): 298-302. |
[4] | Zhang Lili, Tan Ru, Fang Xueli, Yang Yu, Sang Zheng, Li Baosheng. Imaging diagnosis, pathological upgrade, and imaging technology progress of ductal carcinoma in situ of the breast [J]. Journal of International Oncology, 2024, 51(3): 166-169. |
[5] | Peng Qin, Cai Yuting, Wang Wei. Advances on KPNA2 in liver cancer [J]. Journal of International Oncology, 2024, 51(3): 181-185. |
[6] | Jin Xudong, Chen Zhongjian, Mao Weimin. Research progress on the role of MTAP in malignant mesothelioma [J]. Journal of International Oncology, 2024, 51(2): 99-104. |
[7] | He Jiahui, Hu Qinyong. Comparative analysis of lung cancer incidence and mortality trends and risk factors in China and the United States based on GBD data [J]. Journal of International Oncology, 2024, 51(1): 29-36. |
[8] | Huang Zhen, Chen Yongshun. Research progress of circulating tumor DNA in the diagnosis and treatment of hepatocellular carcinoma [J]. Journal of International Oncology, 2024, 51(1): 59-64. |
[9] | Wang Jing, Xu Wenting. Value of NLR, CEA combined with coagulation indicators in the differential diagnosis of benign and malignant breast nodules with a diameter ≤ 1.0 cm [J]. Journal of International Oncology, 2023, 50(9): 520-526. |
[10] | Shandong Medical Association Multidisciplinary Joint Committee on Lung Cancer. Shandong Provincial Medical Association multidisciplinary standardized diagnosis and treatment guidelines for esophageal carcinoma (2023 Edition) [J]. Journal of International Oncology, 2023, 50(7): 385-397. |
[11] | Ju Yifan, Xu Chenyang, Lei Dapeng. Research progress of pathomics in head and neck neoplasms [J]. Journal of International Oncology, 2023, 50(5): 294-298. |
[12] | Xiong Min, Chen Yi, Wang Jianbo. Value of CT radiomic features in differential diagnosis of lung metastases [J]. Journal of International Oncology, 2023, 50(4): 208-213. |
[13] | Zuo Xiaoping, Liu Xiaochuan, Wu Xiqiang, Li Zhou, Xia Tian, Liu Guofeng. Risk factors and prediction model construction of arrhythmia in elderly patients with early lung cancer after thoracoscopic pulmonary resection [J]. Journal of International Oncology, 2023, 50(12): 711-716. |
[14] | Chen Yu, Xu Hua, Liu Hai, Chen Shixin. Construction of pathological classification prediction model for malignant pulmonary pure ground-glass nodule patients based on CT imaging [J]. Journal of International Oncology, 2023, 50(11): 655-660. |
[15] | Qian Weiwei, Xu Shen, Kong Qi. Differential diagnosis value of D-dimer before operation in renal oncocytoma and chromophobe renal cell carcinoma [J]. Journal of International Oncology, 2023, 50(10): 614-617. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||